PRESS RELEASE published on 10/04/2023 at 18:57, 2 years 2 months ago Marcel Lux III SARL: Announcement of the fulfillment of the Offer Condition; settlement of the Offer
PRESS RELEASE published on 09/27/2023 at 14:38, 2 years 2 months ago Marcel Lux III SARL: Publication of the final acceptances of the of the voluntary public purchase offer by Marcel LUX III SARL for the acquisition of shares in SUSE S.A.
PRESS RELEASE published on 08/24/2023 at 18:09, 2 years 3 months ago Marcel Lux III SARL: Notification of Publication of Offer Document
PRESS RELEASE published on 08/17/2023 at 20:02, 2 years 3 months ago Marcel Lux III SARL: EQT Private Equity to take SUSE private and work towards full potential in private setting, with shareholders given option to remain invested or sell at attractive cash offer
PRESS RELEASE published on 08/17/2023 at 19:57, 2 years 3 months ago Marcel Lux III SARL: Announcement of a voluntary public purchase offer by Marcel LUX III SARL for the acquisition of shares in SUSE S.A.
Published on 12/05/2025 at 02:35, 4 hours 3 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 38 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 33 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 38 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 8 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 47 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 13 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 23 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 28 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:14, 12 hours 23 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 12 hours 38 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 12 hours 38 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 53 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 12 hours 53 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
